enGene Therapeutics (ENGN) Tax Provisions (2023 - 2025)
enGene Therapeutics (ENGN) posted quarterly Tax Provisions of -$497000.0 for Q4 2025, down 2715.79% year-over-year from $19000.0 in Q4 2024, and down 307.95% quarter-over-quarter from $239000.0 in Q3 2025.
enGene Therapeutics (ENGN) Tax Provisions (2023 - 2025) Analysis & Trends
enGene Therapeutics (ENGN) has reported Tax Provisions for 3 consecutive years, with -$497000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Tax Provisions fell 2715.79% year-over-year to -$497000.0; the TTM figure through Apr 2026 stood at -$258000.0 (down 204.03% YoY), while the FY2024 annual figure was -$19000.0, down 211.76% from the prior year.
- Tax Provisions fell to -$497000.0 in Q4 2025 per ENGN's latest filing, from $239000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $240000.0 in Q2 2025 and bottomed at -$497000.0 in Q4 2025.
- Historically, Tax Provisions has averaged -$222.22 across 3 years, with a median of $18000.0 in 2025.
- On a YoY basis, Tax Provisions climbed as much as 1042.86% in 2025 and fell as far as 2715.79% in 2025.
- enGene Therapeutics' Tax Provisions stood at $17000.0 in 2023, then grew by 11.76% to $19000.0 in 2024, then sank by 2715.79% to -$497000.0 in 2025.
- Business Quant data shows ENGN's Tax Provisions at -$497000.0 in Q4 2025, $239000.0 in Q3 2025, and $240000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | enGene Therapeutics | 124.11 Mn | 124.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -497,000.00 |
| Jul 31, 2025 | 239,000.00 |
| Apr 30, 2025 | 240,000.00 |
| Jan 31, 2025 | 18,000.00 |
| Oct 31, 2024 | 19,000.00 |
| Jul 31, 2024 | -29,000.00 |
| Apr 30, 2024 | 21,000.00 |
| Jan 31, 2024 | -30,000.00 |
| Oct 31, 2023 | 17,000.00 |